What changed in Penumbra, Inc's latest annual report
In the year ended 31 Dec 2025, Penumbra, Inc's revenue rose 17.5% to USD 1.40bn, from USD 1.19bn; net income rose 1168.1% to USD 177.69m, from USD 14.01m; cash and cash equivalents fell 42.4% to USD 186.90m, from USD 324.40m.
Year ended 31 Dec 2025. Source: 10-K filed 25 Feb 2026, read it on SEC EDGAR.
USD 1.19bn to USD 1.40bn
The figures, year on year
| Item | Year before | Latest year | Change |
|---|---|---|---|
| Revenue | 1.19bn | 1.40bn | Up 17.5% |
| Net income | 14.01m | 177.69m | Up 1168.1% |
| Total assets | 1.53bn | 1.83bn | Up 19.1% |
| Total liabilities | 382.25m | 398.92m | Up 4.4% |
| Cash and cash equivalents | 324.40m | 186.90m | Down 42.4% |
| Shareholders' equity | 1.15bn | 1.43bn | Up 24% |
Questions people ask
Did Penumbra, Inc's revenue grow last year?
Revenue grew 17.5%, from USD 1.19bn to USD 1.40bn in the year ended 31 Dec 2025.
Is Penumbra, Inc profitable?
Yes. Net income was USD 177.69m in the year ended 31 Dec 2025. The year before: USD 14.01m.
How much cash and debt does Penumbra, Inc have?
At its latest year end (31 Dec 2025), Penumbra, Inc reported cash and cash equivalents of USD 186.90m.
Where do these numbers come from?
From Penumbra, Inc's own annual filings with the SEC. Each change is calculated from the reported figures; nothing is estimated.
Meeting a client who works with Penumbra, Inc?
LYNORIQ remembers every client meeting the way this page tracks a filing: what changed since last time, what you promised, and what they owe you.
Start free See the demoOther Surgical & Medical Instruments & Apparatus companies
- Stryker CorpLong-term debt up 21.9%
- 3M CompanyShareholders' equity up 22.4%
- Boston Scientific CorporationCash and cash equivalents up 374.6%
- Becton, Dickinson And CompanyCash and cash equivalents down 62.7%
- Medline Inc.Cash and cash equivalents up 874.4%
- ResMed Inc.Long-term debt down 39.3%
- Dexcom, Inc.Cash and cash equivalents up 51.4%
- West Pharmaceutical Services, Inc.Cash and cash equivalents up 63.3%